19. October 2022

Co-authored posters at ICDS 2022

The 19th International Celiac Disease Symposium (ICDS) will be held from 19.10.2022 - 22.10.2022 in Sorrento, Italy. Leading experts come together to promote important scientific advancements. Please follow the link for details: ICDS

Zedira co-authors three posters in cooperation with leading scientists in academia and industry, e.g. Tampere University and Jilab Inc. (Finland), Mc Master University (USA), University Medical Center of Johannes Gutenberg University Mainz (Germany), and Dr Falk Pharma GmbH (Germany) to present recent advancements evaluating TG2 inhibitor ZED1227 in celiac disease.

246_466 - ORAL TRANSGLUTAMINASE 2 INHIBITOR ZED1227 ACCUMULATES ON THE VILLOUS ENTEROCYTE SURFACE IN CELIAC DISEASE PATIENTS DURING GLUTEN CHALLENGE AND DRUG TREATMENT
Jorma Isola, Markku Mäki, Keijo Viiri, Valeriia Dotsenko, Martin Hils, Ralf Pasternack, Detlef Schuppan, Timo Zimermann, Ralf Mohrbacher, Roland Greinwald

247_467 - ATTENUATION OF INFLAMMATION BY TRANSGLUTAMINASE INHIBITOR ZED1227 IN A CELIAC DISEASE PHASE II GLUTEN CHALLENGE TRIAL CEC-3_CEL.
Jorma Isola, Ralf Mohrbacher, Roland Greinwald, Martin Hils, Ralf Pasternack, Detlef Schuppan, Heini Huhtala, Markku Mäki

243_386 - THE ORAL TISSUE TRANSGLUTAMINASE INHIBITOR ZED1227 PREVENTS GLUTEN-INDUCED ENTEROPATHY IN A HUMANIZED MOUSE MODEL OF CELIAC DISEASE
Manuel Encalada, Hicham El Mard, Aline Pesi, Kaja Sajko, Florian Röhr, Fitriasari Fitriasari, Redouane Krini, Rambabu Surabattula, Martin Hils, Bernhard Tewes, Ralf Pasternack, Roland Greinwald, Sebastian Steven, Victor F Zevallos, Elena F. Verdu, Detlef Schuppan

Visit the Zedira booth at the event!

Document

News

Blog

Events